Description: WuXi AppTec Co., Ltd. is a China-based investment holding company principally engaged in the provision of new drug research and development (R&D), production and supporting services, as well as related technology platform services. The Company is mainly engaged in the discovery, development and production of small molecule drugs, cell therapies and gene therapies, as well as providing testing services for medical devices. The Company mainly conducts its businesses through four segments, including China-based Laboratory Services segment, Contract Manufacturing organization/contract development and manufacturing organization services (CMO/CDMO services) segment, US-based Laboratory Services segment and Clinical Research segment.
Home Page: www.wuxiapptec.com
288 Fute Zhong Road
Shanghai,
200131
China
Phone:
86 21 5046 1111
Officers
| Name | Title |
|---|---|
| Dr. Ge Li Ph.D. | Co-Founder, Chairman, Pres & CEO |
| Dr. Minzhang Chen Ph.D. | Co-Chief Exec. Officer & Exec. Director |
| Dr. Qing Yang Ph.D. | Co-CEO & Exec. Director |
| Dr. Edward Hu M.B.A. | Vice Chairman & Global Chief Investment Officer |
| Ms. Ming Shi | Sr. VP & CFO |
| Dr. Shuhui Chen Ph.D. | Chief Scientific Officer & Exec. VP |
| Mr. Kyler Lei | IR Director |
| Mr. Yao Chi | Joint Company Sec. & Exec. Director of the Corp. Legal Office |
| Dr. Howard Wu J.D. | Sr. VP, Gen. Counsel & Global Head of HR |
| Mr. Zhaohui Zhang | COO of China, Exec. VP & Director |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 19.802 |
|---|---|
| Trailing PE: | 29.4214 |
| Price-to-Book MRQ: | 4.6305 |
| Price-to-Sales TTM: | 0.9452 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 45646 |